Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Migraine Prophylaxis
NCT00301665Phase 2Completed
- Sponsor
- Ipsen
- Start
- Feb 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of abobotulinumtoxinA in migraine, sponsored by Ipsen. Started Feb 2003; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00301665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301665.